Cinnoline derivatives and use as medicine

Details Cinnoline derivatives and use as medicine Cinnoline derivatives and use as medicine

2006-08-08

2006-08-08

Pryor, Alton (Department: 1616)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S248000, C514S228200

Reexamination Certificate

active

07087602

ABSTRACT:
The invention relates to the use of cinnoline derivatives of formula (I)wherein Z represents —O—, —NH—, —S— or —CH2—; m is an integer from 1 to 5; R1represents hydrogen, hydroxy, halogeno, nitro, cyano, trifluoromethyl, C1-3alkyl, C1-3alkoxy, C1-3alkylthio or NR6R7(wherein R6and R7, which may be the same or different, each represents hydrogen or C1-3alkyl); R2represents hydrogen, hydroxy, fluoro, chloro, methoxy, amino or nitro; R3represents hydroxy, halogeno, C1-3alkyl, C1-3alkoxy, C1-3alkanoyloxy, trifluoromethyl, cyano, amino or nitro; R4represents hydrogen, hydroxy, halogeno, cyano, nitro, amino, trifluoromethyl, C1-3alkyl or a group R5—X1(wherein X1represents —O—, —CH2—, —S—, —SO—, —SO2—, —NR8CO—, —CONR9−, —SO2NR10—, —NR11SO2— or —NR12— (wherein R8, R9, R10, R11and R12each independently represents hydrogen, C1-3alkyl or C1-3alkoxy C2-3alkyl) and R5is an optionally substituted alkyl, carbocylic or heterocylic group which may be saturated or unsaturated and may be directly linked to the cinnoline ring or be linked via a carbon chain which may have heteroatom linking groups within it and salts thereof, in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human being, processes for the preparation of such derivatives, pharmaceutical compositions containing a compound of formula (I) or a pharmaceutically acceptable salt thereof as active ingredient and compounds of formula (I). The compounds of formula (I) and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.

REFERENCES:
patent: 4957925 (1990-09-01), Gubin et al.
patent: 4994474 (1991-02-01), Gubin et al.
patent: 5017579 (1991-05-01), Gubin et al.
patent: 5145843 (1992-09-01), Arnold et al.
patent: 5147878 (1992-09-01), Gubin et al.
patent: 5182291 (1993-01-01), Gubin et al.
patent: 5215988 (1993-06-01), Gubin et al.
patent: 6514971 (2003-02-01), Thomas et al.
patent: 0326330 (1989-08-01), None
patent: 0302793 (1989-09-01), None
Barber et al., “A New Cinnoline Synthesis. Part VI.14-Mercaptocinnolines”, J. Chem. Soc., vol. 9, 1968, pp. 1156-1158.
Castle et al., “Cinnoline Chemistry. I. Some Condensation Reaction of 4-Chlorocinnoline”, J. Org. Chem., vol. 17, 1952, pp. 1571-1575.
Castle et al., “Cinnoline Chemistry. II. The Condensation of 4-Methylcinnoline with Aldehydes”, J. Org. Chem., vol. 18, 1953, pp. 1706-1708.
Castle et al., “Cinnoline Chemistry. III. Substituted 4-Cinnolyl-Acetonitriles”, J. Org. Chem., vol. 19, 1954, pp. 1117-1123.
Castle et al., “Cinnoline Chemistry. IV. Infrared Spectra”, Journal of the American Pharmaceutical Association, vol. 48, 1959, pp. 135-139 (including Abstract, 3-Electronic Phenomena, 1959, cols. 8809-8810.
Castle et al., “Cinnoline Chemistry. V. 4-Mercaptocinnolines and Related Compounds”, J. Org. Chem., vol. 25, 1960, pp. 570-572.
Castle et al., “Cinnoline Chemistry. IX. 5- ,6-, 7- and 8-Halogen Substituted Mercaptocinnolines and Related Compounds (1).”, J. Het. Chem. vol. 1, 1964, pp. 98-106.
Castle et al., “Cinnoline Chemistry. XII. The Syntehsis of 6-Flouro-4-methylcinnoline and other Cinnolines as Potential Antitumor Agents (1)”, J. Het. Chem., vol. 2, 1965, pp. 459-462.
Hayashi et al., “Cinnoline . . . 4-(Methylsulfonyl)-cinnoline . . . Cinnolines. II.1)On the Reaction of 4-(Methylsufonyl)-cinnoline with Nucleophiles”, Yakagaku Zasshi, vol. 88(1), 1968, pp. 94-97
Kaushal et al., “Studies in Cinnolinebenzothiazine Derivatives . . . 7H-Cinnolino[4,3-b]-1,4-benzothiazines & Their Derivatives”, Indian J. Chem., vol. 6, Jul. 1968, pp. 350-352.
Lunt et al., “A New Cinnoline Synthesis. Part V. 4-Substituted Amino-cinnolines as Potential Antiprotozoal Agents”, J. Chem. Soc., vol. 9, 1968, pp. 1152-1155.
Rewcastle et al., “Tyronsine Kinase Inhibitors. 5. Synthesis and Structure- . . . Domain of the Epidermal Growth Factor Receptor”, J. Med. Chem., vol. 38, 1995, pp. 3482-3487.
Yarnal et al., “Studies in Cinnoline Chemistry. I. The Synthesis of Substituted Phenyl Cinnolyl Sulfide”, J. Med. Chem., vol. 11, 1968, p. 1270.
Yarnal et al., “Studies in Cinnoline Chemistry: Part III-synthesis of Substituted Phenyl Cinnolyl Sulphides, Sulphone-N-oxides & Sulphones”, Indian Journal of Chemistry, vol. 11, March 1973, pp. 211-213; Chemical Abstracts, vol. 79, No. 9, 9173, Abstract No. 53246x.
Yarnal et al., “Studies in Cinnoline Chemistry-IV The Synthesis of Substituted Phenyl Cinnolyl Ethers”, Journal of the Karnatak University-Science, Dhawar-3, India, vol. 18, 1973, pp. 25-30; Chemical Abstracts, vol. 82, No. 28, 1975, Abstract No. 43302k.
Yarnal et al., “Studies in Cinnoline Chemistry-V The Synthesis of Substituted Arylamino Cinnolines”, Karnatak University, Dharwad, Sci., vol. 29, 1984, pp. 82-86; Chemical Abstracts, vol. 104, No. 25, 1986, Abstract No. 224864p.
Yarnal et al., “Synthese von substituierten Phenylcinnolyl-Sulfiden und Sulfonen”, Arch. Pharm. (Weinheim), vol. 303(7), 1970, pp. 560-562; Chemical Abstracts: vol. 73, No. 15, 1970, Abstract No. 77174z.

Affiliated with

Also associated with

Rating

Cinnoline derivatives and use as medicine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cinnoline derivatives and use as medicine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cinnoline derivatives and use as medicine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3707456